mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.002 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.007 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |